Retreatment tuberculosis in a South African community: The role of re-infection, HIV and antiretroviral treatment

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1510-1516

  Middelkoop, Keren ^a   Bekker, L G ^a   Shashkina, E ^b   Kreiswirth, B ^b   Wood, R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Antiretroviral therapy; HIV; Molecular epidemiology; Re infection; Retreatment tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; DRUG TREATMENT FAILURE; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETREATMENT; SEX DIFFERENCE; SOUTH AFRICA; SPUTUM SMEAR;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; FEMALE; GENOTYPE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; RETREATMENT; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84867191062     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0049     Document Type: Article

References (22)

1. Garcia-Garcia M L, Small P M, Garcia-Sancho C, et al. Tuberculosis epidemiology and control in Veracruz, Mexico. Int J Epidemiol 1999; 28: 135-140. (Pubitemid 29086224)
2. Cape Town TB Control. Progress report 1997-2003. Cape Town, South Africa: Health Systems Trust, 2004. http://www. hst.org.za./publications/618 Accessed July 2012.
3. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179. (Pubitemid 29480655)
4. Verver S, Warren R M, Beyers N, et al. Rate of re-infection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171: 1430-1435. (Pubitemid 40800517)
5. Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693. (Pubitemid 33124328)
6. Crampin A C, Mwaungulu J N, Mwaungulu F D, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS 2010; 24: 417-426.
7. Lawn S D, Myer L, Edwards D, Bekker L G, Wood R. Shortterm and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009; 23: 1717-1725.
8. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007; 175: 87-93. (Pubitemid 46105314)
9. Middelkoop K, Bekker L G, Myer L, et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 2010; 182: 1080-1085.
10. Department of Health, Republic of South Africa. National tuberculosis management guidelines. Pretoria, South Africa: Department of Health, 2009. http://familymedicine.ukzn.ac.za/Libraries/Guidelines-Protocols/ TB-Guidelines-2009.sflb.ashx Accessed July 2012.
11. Middelkoop K, Bekker L G, Myer L, et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011; 56: 263-269.
12. Middelkoop K, Bekker L G, Liang H, et al. Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study. BMC Infect Dis 2011; 11: 156.
13. Middelkoop K, Bekker L G, Mathema B, et al. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009; 200: 1207-1211.
14. Johnson L F, Kranzer K, Middelkoop K, Wood R. A model of the impact of HIV/AIDS and antiretroviral treatment in the Masiphumelele community. Cape Town, South Africa: Centre for Infectious Disease Epidemiology and Research working paper, 2011.
15. Bifani P J, Mathema B, Liu Z, et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999; 282: 2321-2327. (Pubitemid 30013063)
16. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409. (Pubitemid 23028649)
17. Actuarial Society of South Africa. AIDS and demographic model. Cape Town, South Africa: ASSA, 2005. http://aids.actuarialsociety.org.za/ASSA2003-Model- 3165.htm Accessed July 2012.
18. Cox D R, Stuart A. Some quick sign tests for trend in location and dispersion. Biometrika 1955; 42: 80-95.
19. Small P M, Shafer R W, Hopewell P C, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-1144. (Pubitemid 23105750)
20. Caminero J A, Pena M J, Campos-Herrero M I, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 2001; 163: 717-720. (Pubitemid 32230835)
21. Golub J E, Durovni B, King B S, et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2008; 22: 2527-2533.
22. Daley C L, Small P M, Schecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-235.